Skip to Content

Tuberculin

Last Updated: March 6, 2020
Status: Resolved

Reason for the Shortage
    • Par has Aplisol available.
    • Sanofi Pasteur has Tubersol available.
Available Products
    • Aplisol injection, Par Pharmaceuticals, 5 TU/0.1 mL, 1 mL multiple dose vial, NDC 42023-0104-01
    • Aplisol injection, Par Pharmaceuticals, 5 TU/0.1 mL, 5 mL multiple dose vial, NDC 42023-0104-05
    • Tubersol injection, Sanofi Pasteur, 5 TU/0.1 mL, 1 mL multiple dose vial, NDC 49281-0752-21
    • Tubersol injection, Sanofi Pasteur, 5 TU/0.1 mL, 5 mL multiple dose vial, NDC 49281-0752-22

Estimated Resupply Dates

    • All presentations are available.

Implications for Patient Care

    • CDC has additional information regarding the anticipated tuberculin shortage as well as management strategies on their website at https://emergency.cdc.gov/han/han00420.asp. The supply interruption is estimated to begin in June 2019 and continue for approximately 3 to 10 months.

Updated

Updated March 6, 2020 by Anthony Trovato, PharmD, BCPS. Created June 12, 2019 by Megan Dryer, PharmD. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.